Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease increasing cardiovascular disease (CVD) morbidity and mortality. Autoantibodies against apolipoprotein A-1 (AAA-1) are a possible novel CVD risk factor promoting inflammation and disrupting cellular lipid homeostasis, tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Sabrina, Bakker, Stephan J. L., Juillard, Catherine, Vossio, Stefania, Moreau, Dimitri, Brandt, Karim J., Mach, François, Dullaart, Robin P. F., Vuilleumier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552329/
https://www.ncbi.nlm.nih.gov/pubmed/37798764
http://dx.doi.org/10.1186/s12967-023-04569-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552329/
https://www.ncbi.nlm.nih.gov/pubmed/37798764
http://dx.doi.org/10.1186/s12967-023-04569-7

Ejemplares similares